Expression of these proteins has been used in CLL lines in vitro, demonstrating that mostly BCL-XL and secondarily Mcl-1, and Bfl-1 overexpression causes complete resistance to single-agent treatment with VTC (35, 51). Here, MCL1 is linked to B-cell chronic lymphocytic leukemia.